
AAV ACTOne Gs-GPCR Assay Kit-β2AR
Price range: $498.00 through $3,598.00
The AAV ACTOne Gs-GPCR Assay Kit-β2AR is designed specifically for screening drugs/compounds that target the Beta-2 adrenergic receptor (β2AR) by combination AAV and ACTOne technologies.
The Beta-2 adrenergic receptor (β2-AR) is a G protein-coupled receptor (GPCR) that is primarily activated by the catecholamines epinephrine (adrenaline) and norepinephrine (noradrenaline). This receptor is widely expressed in tissues such as the lungs, liver, skeletal muscle, and heart. When activated, it primarily couples with the Gs protein, leading to increased cyclic AMP (cAMP) levels. The Beta-2 adrenergic receptor is crucial for mediating smooth muscle relaxation, bronchodilation, glycogenolysis, and vasodilation, making it a key target for treating asthma, COPD, and cardiovascular conditions.
This kit uses AAV vectors with a CMV promoter to co-express the β2AR and cyclic nucleotide-gated (CNG) channel, allowing researchers to conduct high-throughput screening and functional analysis of potential β2AR-targeting compounds. The kit provides a sensitive and reliable method for evaluating the pharmacological properties of β2AR drugs, such as agonists and antagonists, in a live-cell environment.
- SKU: KS001-β2AR
- Targeting GPCR: Human Beta-2 adrenergic receptor (β2AR)
- GPCR Type: Gs-GPCR
- Kit components: AAV-CNG/AAV-β2AR + ACTOne MP Dye
- Storage: -80°C for long term (> 1 year); -20°C for short term(1-2 months); 4 °C for 1-2 weeks.
- Shipping: Dry ice.
The AAV ACTOne GPCR Assay Kits are live-cell-based cAMP biosensor systems designed for rapid and high-throughput functional screening of G-protein coupled receptors (GPCRs) by combination AAV. Kits are available for both Gi-GPCR and Gs-GPCR assays.
AAV ACTOne Gi-GPCR Assay Kits:
| Name | SKU | Price | Buy |
|---|
AAV ACTOne Gs-GPCR Assay Kits:
| Name | SKU | Price | Buy |
|---|
Advantages of AAV ACTOne GPCR Assay Kits:
- Combined ACTOne and AAV Technologies
- Transient Expression of CNG and GPCR
- Real Time Assay on Living Cell
- High Sensitivity and Big assay window
- Both Kinetic and Endpoint Assay
- Easy to use by mixing the AAVs with cells
- Faster setup and time efficiency
- Reduced risk of genetic drift,
- Simplified workflows,
- flexibility in dynamic control of expression
- Low Cost: $498 for one plate

ACTOne GPCR Assay
ACTOne™ is the only high-throughput GPCR screening technology that can directly measure the intracellular changes of the secondary messenger cyclic AMP (cAMP) in living cells, in real-time. It uses a proprietary modified cyclic nucleotide-gated (CNG) channel, which is co-localized with adenylate cyclase at the plasma membrane, as a biosensor of cAMP activity. The CNG channel opens when the cAMP level near the plasma membrane increases, resulting in ion flux and cell membrane depolarization. The influx of cations through the CNG channel can be quantified using fluorescent ion indicators or membrane potential (MP) dyes. It provides information on real time intracellular cAMP changes and is highly sensitive. By combining kinetic and endpoint readouts, we are able to capture and analyze transient responses from endogenous GPCRs and weak responses caused by weak Gs or Gi coupled GPCR activities. Using ACTOne, we are able to detect the subcellular cAMP concentration changes directly caused by GPCR activation. Real-time kinetic readouts minimize artifacts, and provide greater content and more statistically relevant data. The intensity of signal increase caused by GPCR activation is directly related to the receptor number on cell surface. Using ACTOne assay, we were able to detect activities of some endogenous Gs coupled receptors in HEK293 cells that have not been reported in literature. In addition, we have also detected weak Gs coupled activity of a GPCR that was widely considered to be only linked to Gq coupled pathway. The ACTOne assay also provides a useful tool for GPCR de-orphanization.

| Plate | 1-Plate, 2-Plate, 5-Plate, 10-Plate |
|---|


